DECISION SCIENCE FOR LIFE SCIENCES
Decision models and execution discipline for life science leaders navigating complexities across product innovation, portfolio management, and M&A.
Built on operator-led insight and value creation from idea to market.
THE DECISIONS
Along the Business Evolution Lifecycle
Revenue impact
Strategy
Commercial Viability
Translate market insight into actionable asset roadmaps.
NPIs launched
Portfolio
Asset Prioritization
Maximize pipeline value through disciplined capital allocation.
Integrations
M&A
Due Diligence and Integration
Validate external targets through rigorous diligence to secure post-merger value.
Global P&L impact across Sartorius, MilliporeSigma, and advisory.
THE FRAMEWORKS
Architect strategy
Identify high-value opportunities and characterize commercial and technical risks.
Anchor ambition.
Rationalize portfolio
Benchmark and prioritize pipeline assets to maximize capital efficiency.
Optimize returns.
Pressure-test thesis
Quantify synergies and critical failure modes before final deal commitment.
Realize value.
Me-too pipelines
Delayed launches
Missed synergies
Competitor blue oceans